Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Abha
    Junior Member
    • Mar 2010
    • 5

    #16
    Low Enrichments using Lib A EMPCR kits with SV emulsions

    We are seeing similar kind of problems with our emPCR. The enrichment are very low even after increasing the CPB from 1CPB to 8 CPB! The enrichments still remains under 3%. We quantify our libraries using the Kapa QPCR kits which has been working very well previously and we used 1CPB or max 2CPB to get perfect enrichment. But for the last three FLX runs, the enrichment is considerably low even at higher cpb and the readlength have dropped from average 400bp to 250bp.
    Still debating if it is the libraries, thermocycler or the emPCR kit.

    Comment

    • pmiguel
      Senior Member
      • Aug 2008
      • 2328

      #17
      Has anyone tried running the qPCR or emPCR products on a gel or an Agilent Bioanalyzer chip? Might shed some light...

      Could be problems with small amplicon contamination.

      Alas, Roche makes it nearly impossible for the end user to trouble shoot issues of this sort because they so stringently filter low quality sequence reads. So, really, you have no choice but to lay siege to the (generally overburdened) tech support apparatus at Roche.

      (If anyone knows the right parameters to use to completely turn off filtering in the analysis pipeline, please share! I have gotten to the point where I have turned off everything I know of, but still the majority of bad reads are filtered. They just get caught by the "short reads" filter instead of an earlier one.)

      --
      Phillip

      Comment

      • Abha
        Junior Member
        • Mar 2010
        • 5

        #18
        yes we ran the QPCR products on the gel, and we see nice clean single bands, as these were amplicon products and don't expect any small fragments to be around as they have been double cleaned up with Ampure XP

        Comment

        • pmiguel
          Senior Member
          • Aug 2008
          • 2328

          #19
          How about a little of the emPCR aqueous phase? To be clear, we have never tested this, but since it represents the liquid phase of the emPCR reaction, it might give some clues.

          I wonder if using the new GS-FLX+ emPCR reaction conditions would help? It should not be necessary, but if Roche has been tinkering with the kits in preparation for GS-FLX+, there may have been some negative fall out for non-"plus" protocols.

          --
          Phillip

          Comment

          • yaximik
            Senior Member
            • Apr 2011
            • 199

            #20
            So, what is the end result of this interesting discussion? Did you figure out what was the problem, or as often happens it just diasappeared leaving no clues?

            Comment

            • ajthomas
              Senior Member
              • Mar 2010
              • 167

              #21
              Well, in our case (which started the whole discussion), it was indeed a problem with the library prep kits. I'm still not sure how it happened, but several kits all went bad at the same time, even kits we got a few months apart (same lot number, but different orders). We never figured out for sure which enzyme was the problem, but it was something in the library prep kit.

              Comment

              • Abha
                Junior Member
                • Mar 2010
                • 5

                #22
                I don't think the problem has been resolved yet, the enrichments certainly have improved since that time. however now it seems like it is a RL adaptor issue. In our latest run of XLR70 of the 8 Lanes, we had perfect reads on 4 lanes with between 30- 40Mb of data per lane and read lengths of 400plus. however, the other 4 lanes failed miserably at the key pass stage itself ( got only 50k key passes per lane). And the difference between the samples which passed or failed were, the passed lanes had libraries prepared using the MID tag adaptors from May last year and the failed lanes had libraries prepared from standard rapid library adaptors from recently ordered kits. Roche is investigating this issue at this stage.
                Should mention that the enrichments from all the libraies used were perfect with the expected range. I believe the problem is either with the sequencig primer or the sequencing binding site of the adaptor. Waiting to get some feedback from roche regarding this.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 07-24-2026, 12:17 PM
                0 responses
                26 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-23-2026, 11:41 AM
                0 responses
                21 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-20-2026, 11:10 AM
                0 responses
                210 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                78 views
                0 reactions
                Last Post SEQadmin2  
                Working...